Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

The Identification of Novel Therapies for the Treatment of Follicular Dendritic Cell Sarcoma

Bo Wang, MD, Liang Zhang, MD PhD, Lan Pham, PhD, Wenjing Tao, PhD, Hui Zhang, Jingmeng Xie, Wendy Chen, Qingqing Cai, MD PhD, Dehui Zou, MD PhD, Donglu Zhao, MD, Xiuhua Sun, MDPhD, Rong Liang, MD PhD, Jack Wang, Krystle Nomie, PhD, Nathan Fowler, MD, Michael Wang, MD

Blood (2015) 126 (23): 5126.

https://doi.org/10.1182/blood.V126.23.5126.5126

Published: 2015

Journal Articles

Lenalidomide Plus Rituximab for Relapsed or Refractory Diffuse Large B-Cell, Follicular and Transformed Lymphoma: Final Data Analysis of a Phase 2 Trial

Blood (2015) 126 (23): 3969.

https://doi.org/10.1182/blood.V126.23.3969.3969

Published: 2015

Journal Articles

Longterm Outcome of Induction Chemotherapy of P-Gemox Regimen Followed By Extensive Involved-Field Radiotherapy(EIFRT) for Newly Diagnosed Stage I/II Extranodal Natural Killer/T-Cell Lymphoma---a Single Center Experience

Huiqiang Huang, MD, Yan Gao, XiaoXiao Wang, Qingqing Cai, MD, QiChun Cai, Bing Bai, Zheng Yan, Wenqi Jiang, Zhongjun Xia, MD, ZhiMing Li

Blood (2015) 126 (23): 3936.

https://doi.org/10.1182/blood.V126.23.3936.3936

Published: 2015

Journal Articles

Clinical Outcome of P-Gemox ( Pegaspargase, Gemcitabine, Oxaliplatin ) for the Patients with Newly Diagnosed Stage III/IV or Relapsed/Refractory Extranodal Natural Killer/T Cell Lymphoma

Huiqiang Huang, MD, Yan Gao, XiaoXiao Wang, Qingqing Cai, MD, QiChun Cai, Bing Bai, Wei Zhao, Zheng Yan, Wenqi Jiang, MD PhD, Zhongjun Xia, MD, ZhiMing Li

Blood (2015) 126 (23): 1521.

https://doi.org/10.1182/blood.V126.23.1521.1521

Published: 2015

Journal Articles

Potent Inhibition of the Growth and Induction of Apoptosis of Mantle Cell Lymphoma By the Novel Anthracycline Berubicin in Vitro and in Vivo

George Tsourdinis, Hyebin Park, Luhong Sun, MD PhD, Izabela Fokt, PhD, Arumugam Jayakumar, MSc, PhD, Hui Zhang, Qingqing Cai, MD PhD, Dehui Zou, Bingliang Fang, MD PhD, Waldemar Priebe, PhD, Michael Wang, MD, Liang Zhang, MD PhD

Blood (2014) 124 (21): 3106.

https://doi.org/10.1182/blood.V124.21.3106.3106

Published: 2014

Journal Articles

Microrna-374b Suppresses Proliferation and Promotes Apoptosis in T-Cell Lymphoblastic Lymphoma By Repressing Wnt-16 and AKT1 and Is a Promising Predictive Biomarker for Patients Survival

Qingqing Cai, MD PhD, Dong Qian, MD PhD, Kailin Chen, MD, Dan Xie, MD PhD, Huilan Rao, MDPhD, Huiqiang Huang, MD, Xiaofei Sun, MD

Blood (2014) 124 (21): 1638.

https://doi.org/10.1182/blood.V124.21.1638.1638

Published: 2014

Journal Articles

A Novel and Significant Predictor in Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: The Prognostic Nutritional Index (PNI)

Qingqing Cai, MD PhD, Kailin Chen, MD, Huilan Rao, MDPhD, Wenqi Jiang, MD PhD, Huiqiang Huang, MD, Tongyu Lin, MDPhD, Zhongjun Xia, MD

Blood (2014) 124 (21): 1650.

https://doi.org/10.1182/blood.V124.21.1650.1650

Published: 2014

Journal Articles

Hepatitis B e Antibody Positive before Rituximab Combination Chemotherapy Is Associated with a Lower Risk of Hepatitis B Virus (HBV) Reactivation in HBV Carriers with Diffuse Large B-Cell Lymphoma

Qingqing Cai, MD PhD, Kailin Chen, MD, Qirong Geng, MD, Guangzheng Zhong, MD, Jianping Li, MD, Huiqiang Huang, MD, Tongyu Lin, MDPhD, Wenqi Jiang, MD PhD, Zhiming Li, MD PhD

Blood (2014) 124 (21): 1655.

https://doi.org/10.1182/blood.V124.21.1655.1655

Published: 2014

Journal Articles

Novel Combination Of Lenalidomide-Rituximab Provides An Effective Bridge To Stem Cell Transplantation In Relapsed and/Or Refractory Aggressive B-Cell Non-Hodgkin’s Lymphomas: A Single Center Experience

Qingqing Cai, MD, PhD, Yiming Chen, MD., PhD., Dehui Zou, Maria Badillo, BS, Shouhao Zhou, PhD, Liang Zhang, MD, PhD, Elyse R Lopez, Wenqi Jiang, MD, PhD, Hui-qiang Huang, MD, PhD, Tongyu Lin, MD, PhD, Michael Wang, MD

Blood (2013) 122 (21): 3056.

https://doi.org/10.1182/blood.V122.21.3056.3056

Published: 2013

Journal Articles

A New Prognostic Model for Extranodal Natural Killer/T Cell Lymphoma, Nasal Type

Qingqing Cai, MD, PhD, Xiaolin Luo, MD, Ken H. Young, MD, Huiqiang Huang, MD, PhD, Guanrong Zhang, MD, Tongyu Lin, MD, PhD, Wenqi Jiang, MD, PhD, Zhongjun Xia, MD

Blood (2013) 122 (21): 1769.

https://doi.org/10.1182/blood.V122.21.1769.1769

Published: 2013

NARROW

The Identification of Novel Therapies for the Treatment of Follicular Dendritic Cell Sarcoma

Lenalidomide Plus Rituximab for Relapsed or Refractory Diffuse Large B-Cell, Follicular and Transformed Lymphoma: Final Data Analysis of a Phase 2 Trial

Longterm Outcome of Induction Chemotherapy of P-Gemox Regimen Followed By Extensive Involved-Field Radiotherapy(EIFRT) for Newly Diagnosed Stage I/II Extranodal Natural Killer/T-Cell Lymphoma---a Single Center Experience

Clinical Outcome of P-Gemox ( Pegaspargase, Gemcitabine, Oxaliplatin ) for the Patients with Newly Diagnosed Stage III/IV or Relapsed/Refractory Extranodal Natural Killer/T Cell Lymphoma

Potent Inhibition of the Growth and Induction of Apoptosis of Mantle Cell Lymphoma By the Novel Anthracycline Berubicin in Vitro and in Vivo

Microrna-374b Suppresses Proliferation and Promotes Apoptosis in T-Cell Lymphoblastic Lymphoma By Repressing Wnt-16 and AKT1 and Is a Promising Predictive Biomarker for Patients Survival

A Novel and Significant Predictor in Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: The Prognostic Nutritional Index (PNI)

Hepatitis B e Antibody Positive before Rituximab Combination Chemotherapy Is Associated with a Lower Risk of Hepatitis B Virus (HBV) Reactivation in HBV Carriers with Diffuse Large B-Cell Lymphoma

Novel Combination Of Lenalidomide-Rituximab Provides An Effective Bridge To Stem Cell Transplantation In Relapsed and/Or Refractory Aggressive B-Cell Non-Hodgkin’s Lymphomas: A Single Center Experience

A New Prognostic Model for Extranodal Natural Killer/T Cell Lymphoma, Nasal Type

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only